Eagle Pharmaceuticals Inc

General

Total Cases48
Active Cases6
Patents16
TypeOperating Company
Elite Ratings
--

Ratings

Experience
Grade
Trend
DCT
L2
D
PTAB
--
--
--
CAFC
L2
C

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
01/17/25
Summons Issued as to Slayback Pharma LLC on 1/17/2025. (scs) (Entered: 01/17/2025)
01/17/25
Summons Issued as to Apotex Corp. on 1/17/2025; Apotex Inc. on 1/17/2025. (Attachments: # [1] Summons Issued)(cdd) (Entered: 01/17/2025)
01/17/25
Summons Issued as to Baxter Healthcare Corporation on 1/17/2025. (jfm) (Entered: 01/17/2025)
01/17/25
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed - filed by Eagle Pharmaceuticals, Inc. (cdd) (Entered: 01/17/2025)
01/17/25
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Eagle Pharmaceuticals, Inc. (jfm) (Entered: 01/17/2025)
01/17/25
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Eagle Pharmaceuticals, Inc.. (scs) (Entered: 01/17/2025)
01/17/25
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,138,248. (scs) (Entered: 01/17/2025)
01/17/25
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,138,248. (jfm) (Entered: 01/17/2025)
01/17/25
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,138,248. (cdd) (Entered: 01/17/2025)
01/17/25
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cdd) (Entered: 01/17/2025)